Disperazol

An antibiofilm approach that enhances the current arsenal of antibiotics against multi-drug resistant Gram-negative infections.

About Disperazol

Disperazol is a Cardiff, Wales, United Kingdom based SME that is developing compounds that dismantle biofilms of critical Gram—negative pathogens.

The science
The story so far

Leadership team

  • Image of Prof Michael Givskov.

    Prof Michael Givskov

    Head of Science

  • Image of Dr Michael Graz.

    Dr Michael Graz

    CEO

Meet the team

Contact

Contact us to find out more or with any collaboration queries.

Dr Michael Graz

mgraz@disperazolpharma.com
+44 78 76 59 86 40

Prof Michael Givskov

mgivskov@sund.ku.dk
+45 21 40 98 67

13 years

In development

$500,000

Investment required to expand activity against further critical Gram-negative pathogens

3

Indications

Part of the INCATE cohort

Member of the BEAM Alliance